Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Professor Jan Rehwinkel, a group leader in the MRC Human Immunology Unit, who was named last week as one of 25 new EMBO Young Investigators.

Jan Rehwinkel 2016

Professor Rehwinkel joins a network of 74 current and 382 past Young Investigators who represent some of the best young group leaders in the life sciences in Europe and beyond.

“The EMBO Young Investigator Programme supports young life scientists in their most demanding career phase, when they establish their own research group,” says Maria Leptin, EMBO Director. “Each of the successful candidates has shown great potential to deliver world-class research, and we look forward to supporting them.”

The Young Investigator Programme provides support for researchers under forty years of age who have set up their first laboratories in the past four years. During their three-year tenure, EMBO Young Investigators receive a range of benefits, including an award of 15,000 euros and the opportunity to apply for additional funds to support the establishment of their first independent laboratories.

Laboratory management and non-scientific skills training as well as PhD courses offer the young group leaders and their students the chance to develop professional skills. The scientists also receive access to core facilities at EMBL and funding for themselves and their group members to attend conferences.

This year the programme received 211 applications, and 12 per cent of the candidates who applied were selected.

The next application deadline is 1 April 2017. More information can be found at http://www.embo.org/funding-awards/young-investigators

Similar stories

New study maps the development of the human intestine

MRC HIU RDM

Researchers in the Simmons lab chart the embryonic origins and appearance of diverse intestinal cellular compartments, with important implications for intestinal diseases.

MRC HIU appoints new Director

MRC HIU RDM

We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.

Study uncovers how low blood iron diminishes immune response

MRC HIU NDM RDM

The Drakesmith group finds that low blood serum iron levels can inhibit T-cell and B-cell immune responses to vaccines and infections.

Study finds new human blood disorder

MRC MHU RDM

The Patel Group have discovered a new human disease caused by formaldehyde accumulation in cells

Interferon-b trial shows positive results

COVID-19 MRC HIU NDM

A trial of a new inhaled antiviral drug for COVID-19 has shown positive results and the drug is now moving into a larger international phase 3 trial of hospitalised patients. MRC HIU's Professor Ling-Pei Ho is one of the main co-authors on the paper.